Gillette India faces a challenging Q1 FY 2026-2027 as it navigates persistent raw material cost pressures and a sluggish urban demand environment. Investors will be closely watching the company's ability to balance pricing power against volume growth while managing an elevated inventory position.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 309.95 Cr |
| Market cap | Rs. 25,513.08 Cr |
| CMP | Rs. 7,828.5 |
The board of directors is scheduled to meet on July 30, 2026, to consider and approve the audited financial results for the quarter ended June 30, 2026.
Gillette India enters Q1 facing a structural margin headwind as stainless steel prices, while moderating slightly in June, remained approximately 19% higher year-on-year. The company's Q4 FY26 performance showed cost of materials consumed surging 28.9% year-on-year, and management will likely address whether the 167-day inventory level acted as a sufficient buffer against these elevated input costs. With broader FMCG rural volume growth recorded at 7.7% compared to 3.7% in urban markets, the call will focus on whether Gillette is experiencing a similar divergence in its grooming and oral care segments. Management will also need to clarify if the 21.2% year-on-year cut in advertising spend seen in Q4 will be reversed to defend market share in a soft demand environment. Finally, the sustainability of the 35.0% EBITDA margin achieved in Q4 remains a key question, given the potential for higher operational and promotional expenses in the current quarter.
Raw material cost and inventory management: Monitoring the impact of stainless steel price volatility on gross margins.
Demand and segment performance: Tracking the split between rural and urban consumption patterns.
Operational spending and margins: Assessing the sustainability of recent margin expansion.
As of March 31, 2026, the company reported inventory days at approximately 167 days. This level was flagged as elevated and represents a working capital risk for the company.
The 35.0% EBITDA margin in Q4 FY26 was supported by a 21.2% year-on-year reduction in advertising spend. Additionally, depreciation declined 23.0% year-on-year during that period.
The Oral Care segment was a key growth driver throughout FY26, recording a 12.9% year-on-year growth in Q4. Investors are looking to see if this momentum persists in the current quarter.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now